共 286 条
[31]
Kleinschmidt I(2002)MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials - Scientific, regulatory and public health perspectives J Am Statist Ass 97 389-2360
[32]
Schwabe C(2009)A frailty mixture model for estimating vaccine efficacy Infect Immun 77 1917-undefined
[33]
Benavente L(2009)Interpretation and estimation of vaccine efficacy under heterogeneity Malar J 8 242-undefined
[34]
Torrez M(2008)Heterogeneities in the transmission of infectious agents: Implications for the design of control programs Phil Trans R Soc A 366 2347-undefined
[35]
Ridl FC(undefined)Insights into long-lasting protection induced by RTS, S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children undefined undefined undefined-undefined
[36]
Segura JL(undefined)Long-term safety and efficacy of the RTS, S/AS02A malaria vaccine in Mozambican children undefined undefined undefined-undefined
[37]
Ehmer P(undefined)Estimation of waning vaccine efficacy undefined undefined undefined-undefined
[38]
Nchama GN(undefined)Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure undefined undefined undefined-undefined
[39]
Alonso PL(undefined)What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity undefined undefined undefined-undefined
[40]
Sacarlal J(undefined)Estimation of vaccine efficacy in a repeated measures study under heterogeneity of exposure or susceptibility to infection undefined undefined undefined-undefined